Germany’s Bundeskartellamt has cleared under merger control the planned launch of a joint venture by the Phoenix Group subsidiary ADG Apotheken-Dienstleistungsgesellschaft mbH, Mannheim, and the pharmacy services provider Noventi Health SE, Munich.
The joint venture is intended to operate an extensive digital platform for health services and products, which, apart from the purchase and reservation of prescription-only and over-the-counter pharmaceuticals from a pharmacy, is also to enable other functions in the medium term such as e.g. online video consultations with a doctor.
Andreas Mundt, President of the Bundeskartellamt said, “The introduction of the electronic prescription next year will significantly boost innovation in the sale of pharmaceuticals. Different players are currently developing digital offers in this area. In this sensitive market phase we want to make sure that markets remain open and unilateral developments do not occur early on. In particular, it is important for us that the brick-and-mortar pharmacies can be simultaneously connected to several platforms and switch between different offers. Lastly, they should have the possibility to operate their own joint platforms.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI